Dominant TNF-α+ Mycobacterium tuberculosis–specific CD4+ T cell responses discriminate between latent infection and active disease-Reference-Cited by-同舟云学术

Dominant TNF-α+ Mycobacterium tuberculosis–specific CD4+ T cell responses discriminate between latent infection and active disease

Published:2011-02-20 Issue:3 Volume:17 Page:372-376
ISSN:1078-8956
Container-title:Nature Medicine
language:en
Short-container-title:Nat Med

Author:

Harari Alexandre,Rozot Virginie,Enders Felicitas Bellutti,Perreau Matthieu,Stalder Jesica Mazza,Nicod Laurent P,Cavassini Matthias,Calandra Thierry,Blanchet Catherine Lazor,Jaton Katia,Faouzi Mohamed,Day Cheryl L,Hanekom Willem A,Bart Pierre-Alexandre,Pantaleo Giuseppe

Publisher

Springer Science and Business Media LLC

Subject

General Biochemistry, Genetics and Molecular Biology,General Medicine

Link

http://www.nature.com/articles/nm.2299.pdf

Reference22 articles.

1. Kaufmann, S.H. How can immunology contribute to the control of tuberculosis? Nat. Rev. Immunol. 1, 20–30 (2001).

2. Flynn, J.L. & Chan, J. Immunology of tuberculosis. Annu. Rev. Immunol. 19, 93–129 (2001).

3. Lalvani, A. et al. Enhanced contact tracing and spatial tracking of Mycobacterium tuberculosis infection by enumeration of antigen-specific T cells. Lancet 357, 2017–2021 (2001).

4. Ewer, K. et al. Comparison of T cell–based assay with tuberculin skin test for diagnosis of Mycobacterium tuberculosis infection in a school tuberculosis outbreak. Lancet 361, 1168–1173 (2003).

5. Meier, T., Eulenbruch, H.P., Wrighton-Smith, P., Enders, G. & Regnath, T. Sensitivity of a new commercial enzyme-linked immunospot assay (T SPOT-TB) for diagnosis of tuberculosis in clinical practice. Eur. J. Clin. Microbiol. Infect. Dis. 24, 529–536 (2005).

Cited by 344 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cationic pH-sensitive liposome-based subunit tuberculosis vaccine induces protection in mice challenged with Mycobacterium tuberculosis;European Journal of Pharmaceutics and Biopharmaceutics;2024-10

2. Concurrent TB and HIV therapies effectively control clinical reactivation of TB during co-infection but fail to eliminate chronic immune activation;2024-08-26

3. Randomised, double-blind, controlled phase 1 trial of the candidate tuberculosis vaccine ChAdOx1-85A delivered by aerosol versus intramuscular route;Journal of Infection;2024-08

4. Identification of MORN3 and LLGL2 as novel diagnostic biomarkers for latent tuberculosis infection using machine learning strategies and experimental verification;Annals of Medicine;2024-07-25

5. Flow cytometry-based method using diversity of cytokine production differentiates between Mycobacterium tuberculosis infection and disease;Tuberculosis;2024-07